查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1193076

心臟測繪市場：按產品、適應症、最終用戶分類：全球機會分析和行業預測，2021-2031 年

Cardiac Mapping Market By Product, By Indication, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 310 Pages | 商品交期: 2-3個工作天內

價格

全球心臟測繪市場預計到 2021 年將達到 26.25 億美元，到 2031 年將達到 45.7217 億美元，2022 年至 2031 年的複合年增長率為 5.7%。

介入電生理學在過去十年中取得了長足的進步。 心電圖是用於從心電圖收集和呈現信息的最複雜的方法之一。 該技術可識別特定心跳時心臟電信號的地理和時間分佈。 近年來，創新的繪圖技術改變了臨床電生理學實驗室，為瞭解心律失常背後的機制提供了新的見解。 此外，心臟活動圖的分辨率、3D空間定位和採集速度也有了顯著提高。

根據美國疾病控制和預防中心 (CDC) 的數據，每年有超過 454,000 人因房顫作為主要疾病住院。 由於久坐不動的生活方式、肥胖、缺乏運動和壓力導致所有年齡組的心臟病發病率增加，因此預計將大規模銷售心臟測繪系統。

此外，醫療設備製造商引入尖端診斷技術、對嚴重心臟病準確診斷的需求不斷增長，以及受過必要培訓的介入心臟病專家的存在正在推動心臟測繪市場。預計將推動增長的

美國衛生與公眾服務部發起了一項名為 "百萬心臟" 的全國運動，旨在在未來五年（2022 年 1 月至 2026 年 12 月）內預防 100 萬例心臟病發作和中風。它已經開始。 該運動的重點是採用一份由研究支持的優先事項和目標的簡明清單，以改善所有人的心血管健康。 因此，預計政府提供的更多此類舉措和資金將提供推動市場增長的普遍因素。

目次

第 1 章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • COVID-19 影響分析
  • 專利情況

第 4 章心臟測繪市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 聯繫心臟映射系統
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：國家分析
    • 聯繫心臟測繪系統/心臟測繪市場：按類型
      • 解剖電圖市場規模和按地區預測
      • 籃式導管映射市場規模和預測：按地區
      • 傳統心內膜導管測繪市場規模和預測：按地區
  • 非接觸式心臟標測系統
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章心臟測繪市場：按適應症分類

  • 概覽
    • 市場規模和預測
  • 心房小顫動
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 心房撲動
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • AVNRT
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章心臟測繪市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 醫務室
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章心臟測繪市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測：按產品
      • 北美接觸式心臟測繪系統/心臟測繪市場：按類型分類
    • 北美市場規模和預測：按適應症分類
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測：按產品
      • 歐洲接觸式心臟測繪系統/心臟測繪市場：按類型分類
    • 歐洲市場規模和預測：按適應症分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測：按產品
      • 亞太地區接觸式心臟測繪系統/心臟測繪市場：按類型分類
    • 亞太地區的市場規模和預測：按適應症分類
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測：按產品
      • LAMEA 接觸式心臟測繪系統/心臟測繪市場：按類型分類
    • LAMEA 市場規模和預測：按適應症分類
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第 8 章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第 9 章公司簡介

  • Abbott Laboratories
  • Acutus Medical Inc.
  • APN Healthcare
  • BioSig Technologies
  • Boston Bioscientific Corporation
  • EPMap Systems
  • Johnson and Johnson（Biosense Webster）
  • Kardium Inc.
  • Koninklijke Philips
  • Lepu Medical Technology
  • Medtronic Plc.
  • MicroPort Scientific Corporation
Product Code: A10920

The global cardiac mapping market was valued at $2,625.0 million in 2021, and is projected to reach $4,572.17 million by 2031, registering a CAGR of 5.7% from 2022 to 2031.

Over the past ten years, interventional electrophysiology has advanced significantly. One of the most sophisticated methods used to collect and present the information obtained from an ECG is cardiac mapping. The technique involves identifying geographical and temporal distribution of cardiac electrical signals during a specific heartbeat. In recent years, innovative mapping methods have transformed the clinical electrophysiology laboratory and provided fresh insights to the mechanisms behind arrhythmias. In addition, there is a huge improvement in the resolution, three-dimensional spatial localization, and speed of acquisition of cardiac activity maps.

According to the Centers for Disease Control and Prevention, CDC, more than 454,000 hospitalizations with atrial fibrillation as the primary diagnosis happens each year in the U.S. This rise in incidence of cardiovascular diseases among all age groups owing to a sedentary lifestyle, rise in obesity, lack of physical fitness and stress, is expected to lead to sales of cardiac mapping systems on a large scale.

Furthermore, the growth of the cardiac mapping market is anticipated to be facilitated by the introduction of numerous cutting-edge diagnostic technologies by medical device companies, increase in the demand for accurate diagnosis of serious cardiac diseases, and availability of interventional cardiologists with the necessary training in developed economies.

The U.S. Department of Health & Human Services initiated a national campaign called 'Million Hearts', which aims to stop 1 million heart attacks and strokes in the next five years (from January 2022 to December 2026). It focuses on adopting a condensed list of priorities and goals that are supported by research and can enhance cardiovascular health for everyone. Thus, such more initiatives and funding provided by the government are expected to provide prevalence of factors causing the market growth.

In addition, rise in investment for research and development of the advanced and precise diagnostic tools by public and private players in the market with an aim to improve health care infrastructure and increase in adoption by the interventional cardiologists in hospitals are the key factors for the expansion of the cardiac mapping market. For instance, the development of the CardioInsight Noninvasive 3D Mapping System uses a proprietary, single-use, disposable multi-electrode vest to capture electrical signals from the body surface and displays interactive 3-D color maps including activation, composite, and phase maps.

However, the market is expected to be significantly constrained in the near future by factors, such as lack of awareness about these systems in developing nations, expensive price, and minor risks involved in the cardiac mapping operation.

The cardiac mapping market is segmented on the basis of product, indication, end user, and region. By product, it is divided into contact cardiac mapping systems and non-contact cardiac mapping systems. Further, the contact cardiac mapping systems segment is divided into electroanatomical mapping, basket catheter mapping, and traditional endocardial catheter mapping. On the basis of indication, the market is segmented into atrial fibrillation, atrial flutter, AVNRT, and others. According to end user, the market is segmented into hospitals, clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Abbott Laboratories, Acutus Medical Inc., APN Healthcare, BioSig Technologies, Boston Bioscientific Corporation, EPMap Systems, Johnson And Johnson (Biosense Webster), Kardium Inc., Koninklijke Philips, Lepu Medical Technology, Medtronic Plc., MicroPort Scientific Corporation, and others.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiac mapping market analysis from 2021 to 2031 to identify the prevailing cardiac mapping market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cardiac mapping market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cardiac mapping market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By End User

  • Hospitals
  • Clinics
  • Others

By Product

  • Non-contact Cardiac mapping systems
  • Contact Cardiac mapping systems
    • Type
    • Electroanatomical mapping
    • Basket catheter mapping
    • Traditional endocardial catheter mapping

By Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • AVNRT
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Abbott Laboratories
    • Acutus Medical Inc.
    • APN Healthcare
    • BioSig Technologies
    • Boston Bioscientific Corporation
    • EPMap Systems
    • Johnson and Johnson (Biosense Webster)
    • Kardium Inc.
    • Koninklijke Philips
    • Lepu Medical Technology
    • Medtronic Plc.
    • MicroPort Scientific Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: CARDIAC MAPPING MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Contact Cardiac mapping systems
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Contact Cardiac mapping systems Cardiac Mapping Market by Type
      • 4.2.4.1 Electroanatomical mapping Market size and forecast, by region
      • 4.2.4.2 Basket catheter mapping Market size and forecast, by region
      • 4.2.4.3 Traditional endocardial catheter mapping Market size and forecast, by region
  • 4.3 Non-contact Cardiac mapping systems
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: CARDIAC MAPPING MARKET, BY INDICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Atrial Fibrillation
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Atrial Flutter
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 AVNRT
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: CARDIAC MAPPING MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Clinics
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: CARDIAC MAPPING MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
      • 7.2.2.1 North America Contact Cardiac mapping systems Cardiac Mapping Market by Type
    • 7.2.3 North America Market size and forecast, by Indication
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Indication
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Indication
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Indication
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
      • 7.3.2.1 Europe Contact Cardiac mapping systems Cardiac Mapping Market by Type
    • 7.3.3 Europe Market size and forecast, by Indication
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Indication
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Indication
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Indication
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Indication
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Product
      • 7.3.5.5.2 Market size and forecast, by Indication
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product
      • 7.3.5.6.2 Market size and forecast, by Indication
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
      • 7.4.2.1 Asia-Pacific Contact Cardiac mapping systems Cardiac Mapping Market by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Indication
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Indication
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Indication
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Indication
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Indication
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Indication
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Product
      • 7.4.5.6.2 Market size and forecast, by Indication
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
      • 7.5.2.1 LAMEA Contact Cardiac mapping systems Cardiac Mapping Market by Type
    • 7.5.3 LAMEA Market size and forecast, by Indication
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Indication
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Indication
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Indication
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Indication
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbott Laboratories
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Acutus Medical Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 APN Healthcare
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 BioSig Technologies
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Boston Bioscientific Corporation
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 EPMap Systems
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Johnson and Johnson (Biosense Webster)
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Kardium Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Koninklijke Philips
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Lepu Medical Technology
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 Medtronic Plc.
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 MicroPort Scientific Corporation
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. CARDIAC MAPPING MARKET, FOR CONTACT CARDIAC MAPPING SYSTEMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. CARDIAC MAPPING MARKET FOR CONTACT CARDIAC MAPPING SYSTEMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL CONTACT CARDIAC MAPPING SYSTEMS CARDIAC MAPPING MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. CARDIAC MAPPING MARKET, FOR ELECTROANATOMICAL MAPPING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. CARDIAC MAPPING MARKET, FOR BASKET CATHETER MAPPING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. CARDIAC MAPPING MARKET, FOR TRADITIONAL ENDOCARDIAL CATHETER MAPPING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. CARDIAC MAPPING MARKET, FOR NON-CONTACT CARDIAC MAPPING SYSTEMS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. CARDIAC MAPPING MARKET FOR NON-CONTACT CARDIAC MAPPING SYSTEMS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 11. CARDIAC MAPPING MARKET, FOR ATRIAL FIBRILLATION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. CARDIAC MAPPING MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. CARDIAC MAPPING MARKET, FOR ATRIAL FLUTTER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. CARDIAC MAPPING MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. CARDIAC MAPPING MARKET, FOR AVNRT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. CARDIAC MAPPING MARKET FOR AVNRT, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. CARDIAC MAPPING MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. CARDIAC MAPPING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. GLOBAL CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. CARDIAC MAPPING MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. CARDIAC MAPPING MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. CARDIAC MAPPING MARKET, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. CARDIAC MAPPING MARKET FOR CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. CARDIAC MAPPING MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 25. CARDIAC MAPPING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 26. CARDIAC MAPPING MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA CONTACT CARDIAC MAPPING SYSTEMS CARDIAC MAPPING MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 29. NORTH AMERICA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. NORTH AMERICA CARDIAC MAPPING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. U.S. CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 33. U.S. CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 34. U.S. CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. CANADA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 36. CANADA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 37. CANADA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 39. MEXICO CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 40. MEXICO CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE CONTACT CARDIAC MAPPING SYSTEMS CARDIAC MAPPING MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. EUROPE CARDIAC MAPPING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 48. GERMANY CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. UK CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 53. UK CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 54. UK CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. ITALY CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 56. ITALY CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 57. ITALY CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 60. SPAIN CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC CONTACT CARDIAC MAPPING SYSTEMS CARDIAC MAPPING MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC CARDIAC MAPPING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 71. JAPAN CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. CHINA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 73. CHINA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 74. CHINA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 75. AUSTRALIA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 76. AUSTRALIA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 78. INDIA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 79. INDIA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 80. INDIA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. SOUTH KOREA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 82. SOUTH KOREA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 83. SOUTH KOREA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 84. REST OF ASIA-PACIFIC CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 85. REST OF ASIA-PACIFIC CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 86. REST OF ASIA-PACIFIC CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. LAMEA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 88. LAMEA CONTACT CARDIAC MAPPING SYSTEMS CARDIAC MAPPING MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 89. LAMEA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 90. LAMEA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 91. LAMEA CARDIAC MAPPING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 92. BRAZIL CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 93. BRAZIL CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 94. BRAZIL CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 95. SAUDI ARABIA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 96. SAUDI ARABIA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 97. SAUDI ARABIA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 98. SOUTH AFRICA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 99. SOUTH AFRICA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 100. SOUTH AFRICA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101. REST OF LAMEA CARDIAC MAPPING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 102. REST OF LAMEA CARDIAC MAPPING MARKET, BY INDICATION, 2021-2031 ($MILLION)
  • TABLE 103. REST OF LAMEA CARDIAC MAPPING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 104.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 105.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 106.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 107.ABBOTT LABORATORIES: NET SALES,
  • TABLE 108.ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 109.ACUTUS MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 110.ACUTUS MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 111.ACUTUS MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 112.ACUTUS MEDICAL INC.: NET SALES,
  • TABLE 113.ACUTUS MEDICAL INC.: KEY STRATERGIES
  • TABLE 114.APN HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 115.APN HEALTHCARE: OPERATING SEGMENTS
  • TABLE 116.APN HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 117.APN HEALTHCARE: NET SALES,
  • TABLE 118.APN HEALTHCARE: KEY STRATERGIES
  • TABLE 119.BIOSIG TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 120.BIOSIG TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 121.BIOSIG TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 122.BIOSIG TECHNOLOGIES: NET SALES,
  • TABLE 123.BIOSIG TECHNOLOGIES: KEY STRATERGIES
  • TABLE 124.BOSTON BIOSCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 125.BOSTON BIOSCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 126.BOSTON BIOSCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127.BOSTON BIOSCIENTIFIC CORPORATION: NET SALES,
  • TABLE 128.BOSTON BIOSCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 129.EPMAP SYSTEMS: COMPANY SNAPSHOT
  • TABLE 130.EPMAP SYSTEMS: OPERATING SEGMENTS
  • TABLE 131.EPMAP SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 132.EPMAP SYSTEMS: NET SALES,
  • TABLE 133.EPMAP SYSTEMS: KEY STRATERGIES
  • TABLE 134.JOHNSON AND JOHNSON (BIOSENSE WEBSTER): COMPANY SNAPSHOT
  • TABLE 135.JOHNSON AND JOHNSON (BIOSENSE WEBSTER): OPERATING SEGMENTS
  • TABLE 136.JOHNSON AND JOHNSON (BIOSENSE WEBSTER): PRODUCT PORTFOLIO
  • TABLE 137.JOHNSON AND JOHNSON (BIOSENSE WEBSTER): NET SALES,
  • TABLE 138.JOHNSON AND JOHNSON (BIOSENSE WEBSTER): KEY STRATERGIES
  • TABLE 139.KARDIUM INC.: COMPANY SNAPSHOT
  • TABLE 140.KARDIUM INC.: OPERATING SEGMENTS
  • TABLE 141.KARDIUM INC.: PRODUCT PORTFOLIO
  • TABLE 142.KARDIUM INC.: NET SALES,
  • TABLE 143.KARDIUM INC.: KEY STRATERGIES
  • TABLE 144.KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
  • TABLE 145.KONINKLIJKE PHILIPS: OPERATING SEGMENTS
  • TABLE 146.KONINKLIJKE PHILIPS: PRODUCT PORTFOLIO
  • TABLE 147.KONINKLIJKE PHILIPS: NET SALES,
  • TABLE 148.KONINKLIJKE PHILIPS: KEY STRATERGIES
  • TABLE 149.LEPU MEDICAL TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 150.LEPU MEDICAL TECHNOLOGY: OPERATING SEGMENTS
  • TABLE 151.LEPU MEDICAL TECHNOLOGY: PRODUCT PORTFOLIO
  • TABLE 152.LEPU MEDICAL TECHNOLOGY: NET SALES,
  • TABLE 153.LEPU MEDICAL TECHNOLOGY: KEY STRATERGIES
  • TABLE 154.MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 155.MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 156.MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 157.MEDTRONIC PLC.: NET SALES,
  • TABLE 158.MEDTRONIC PLC.: KEY STRATERGIES
  • TABLE 159.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 160.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 161.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 162.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 163.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CARDIAC MAPPING MARKET SEGMENTATION
  • FIGURE 2.CARDIAC MAPPING MARKET,2021-2031
  • FIGURE 3.CARDIAC MAPPING MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CARDIAC MAPPING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATENT ANALYSIS BY COMPANY
  • FIGURE 13.PATENT ANALYSIS BY COUNTRY
  • FIGURE 14.CARDIAC MAPPING MARKET,BY PRODUCT,2021(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF CONTACT CARDIAC MAPPING SYSTEMS CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF NON-CONTACT CARDIAC MAPPING SYSTEMS CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 17.CARDIAC MAPPING MARKET,BY INDICATION,2021(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ATRIAL FIBRILLATION CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ATRIAL FLUTTER CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AVNRT CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 22.CARDIAC MAPPING MARKET,BY END USER,2021(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF CLINICS CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC MAPPING MARKET,2021-2031(%)
  • FIGURE 26.CARDIAC MAPPING MARKET BY REGION,2021
  • FIGURE 27.U.S. CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 28.CANADA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 29.MEXICO CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 32.UK CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 33.ITALY CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 34.SPAIN CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 39.INDIA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 40.SOUTH KOREA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF ASIA-PACIFIC CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 42.BRAZIL CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 43.SAUDI ARABIA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH AFRICA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF LAMEA CARDIAC MAPPING MARKET,2021-2031($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50.COMPETITIVE DASHBOARD
  • FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 52.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 53.ACUTUS MEDICAL INC..: NET SALES ,($MILLION)
  • FIGURE 54.APN HEALTHCARE.: NET SALES ,($MILLION)
  • FIGURE 55.BIOSIG TECHNOLOGIES.: NET SALES ,($MILLION)
  • FIGURE 56.BOSTON BIOSCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 57.EPMAP SYSTEMS.: NET SALES ,($MILLION)
  • FIGURE 58.JOHNSON AND JOHNSON (BIOSENSE WEBSTER).: NET SALES ,($MILLION)
  • FIGURE 59.KARDIUM INC..: NET SALES ,($MILLION)
  • FIGURE 60.KONINKLIJKE PHILIPS.: NET SALES ,($MILLION)
  • FIGURE 61.LEPU MEDICAL TECHNOLOGY.: NET SALES ,($MILLION)
  • FIGURE 62.MEDTRONIC PLC..: NET SALES ,($MILLION)
  • FIGURE 63.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)